These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36358310)

  • 1. TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target.
    Palacios LM; Peyret V; Viano ME; Geysels RC; Chocobar YA; Volpini X; Pellizas CG; Nicola JP; Motran CC; Rodriguez-Galan MC; Fozzatti L
    Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36358310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism.
    Stempin CC; Geysels RC; Park S; Palacios LM; Volpini X; Motran CC; Acosta Rodríguez EV; Nicola JP; Cheng SY; Pellizas CG; Fozzatti L
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 4. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer.
    Choi YS; Jeon MJ; Doolittle WKL; Song DE; Kim K; Kim WB; Kim WG
    Thyroid; 2024 May; ():. PubMed ID: 38666696
    [No Abstract]   [Full Text] [Related]  

  • 6. IL2RA
    Pan Z; Bao L; Lu X; Hu X; Li L; Chen J; Jin T; Zhang Y; Tan Z; Huang P; Ge M
    Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166591. PubMed ID: 36328145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25‑Dihydroxy‑Vitamin D3 induces macrophage polarization to M2 by upregulating T‑cell Ig‑mucin‑3 expression.
    Liang S; Cai J; Li Y; Yang R
    Mol Med Rep; 2019 May; 19(5):3707-3713. PubMed ID: 30896850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.
    Egan CE; Stefanova D; Ahmed A; Raja VJ; Thiesmeyer JW; Chen KJ; Greenberg JA; Zhang T; He B; Finnerty BM; Zarnegar R; Jin MM; Scognamiglio T; Dephoure N; Fahey T; Min IM
    Thyroid; 2021 Oct; 31(10):1481-1493. PubMed ID: 34078123
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.
    Lee C; Jeong H; Bae Y; Shin K; Kang S; Kim H; Oh J; Bae H
    J Immunother Cancer; 2019 Jun; 7(1):147. PubMed ID: 31174610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
    Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.
    Mazzoni M; Mauro G; Erreni M; Romeo P; Minna E; Vizioli MG; Belgiovine C; Rizzetti MG; Pagliardini S; Avigni R; Anania MC; Allavena P; Borrello MG; Greco A
    J Exp Clin Cancer Res; 2019 May; 38(1):208. PubMed ID: 31113465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma.
    Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of novel macrophage related signature in anaplastic thyroid cancer.
    Luo Y; Yang YC; Ma B; Xu WB; Liao T; Wang Y
    Endocrine; 2022 Dec; 78(3):517-530. PubMed ID: 36070052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for anaplastic thyroid carcinoma: the present and future.
    Lu X; Bao L; Pan Z; Ge M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):675-684. PubMed ID: 35347912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
    Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.
    Olsson A; Nakhlé J; Sundstedt A; Plas P; Bauchet AL; Pierron V; Bruetschy L; Deronic A; Törngren M; Liberg D; Schmidlin F; Leanderson T
    J Immunother Cancer; 2015; 3():53. PubMed ID: 26673090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.
    Ning J; Hou X; Hao J; Zhang W; Shi Y; Huang Y; Ruan X; Zheng X; Gao M
    Cell Death Differ; 2023 Oct; 30(10):2265-2279. PubMed ID: 37648786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer.
    Gunda V; Gigliotti B; Ndishabandi D; Ashry T; McCarthy M; Zhou Z; Amin S; Freeman GJ; Alessandrini A; Parangi S
    Br J Cancer; 2018 Nov; 119(10):1223-1232. PubMed ID: 30327563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.